Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
PepsiCo
PEP
$194B
| $8.76M | ﹤0.01% |
47,270
-257,683
| -84% | -$48.1M |
|
2102
HealthStream
HSTM
$841M
| $8.75M | ﹤0.01% |
356,324
-34,495
| -9% | -$856K |
|
|
RVNC
2103
DELISTED
Revance Therapeutics, Inc.
RVNC
| $8.74M | ﹤0.01% |
345,458
+232,891
| +207% | +$7.25M |
|
|
PPBI
2104
DELISTED
Pacific Premier Bancorp
PPBI
| $8.72M | ﹤0.01% |
421,715
+160,989
| +62% | +$3.36M |
|
2105
CALL
AT&T
T
$177B
| $8.72M | ﹤0.01% |
546,300
-216,600
| -28% | -$3.69M |
|
2106
New Mountain Finance
NMFC
$715M
| $8.7M | ﹤0.01% |
699,601
+92,516
| +15% | +$1.12M |
|
2107
Mueller Water Products
MWA
$3.95B
| $8.69M | ﹤0.01% |
535,183
-401,998
| -43% | -$5.72M |
|
2108
iShares MSCI France ETF
EWQ
$337M
| $8.66M | ﹤0.01% |
+224,842
| New | +$8.63M |
|
|
MRO
2109
CALL
DELISTED
Marathon Oil Corporation
MRO
| $8.66M | ﹤0.01% |
376,100
+173,300
| +85% | +$4.08M |
|
2110
McGrath RentCorp
MGRC
$2.79B
| $8.66M | ﹤0.01% |
93,609
-232,841
| -71% | -$21.3M |
|
|
BWIN
2111
Baldwin Insurance Group
BWIN
$2.94B
| $8.66M | ﹤0.01% |
349,282
+328,342
| +1,568% | +$7.77M |
|
2112
National Bank Holdings
NBHC
$1.84B
| $8.65M | ﹤0.01% |
297,989
-1,312
| -0.4% | -$41K |
|
2113
PUT
Kroger
KR
$35.8B
| $8.64M | ﹤0.01% |
183,800
-121,900
| -40% | -$5.81M |
|
2114
CALL
NovoCure
NVCR
$2.08B
| $8.63M | ﹤0.01% |
+207,900
| New | +$12.9M |
|
2115
Community Bank
CBU
$3.32B
| $8.62M | ﹤0.01% |
183,828
+62,933
| +52% | +$3.08M |
|
|
ILPT
2116
Industrial Logistics Properties Trust
ILPT
$563M
| $8.6M | ﹤0.01% |
2,607,544
+1,139,030
| +78% | +$2.54M |
|
2117
PUT
Ferrari
RACE
$72.6B
| $8.59M | ﹤0.01% |
26,400
-4,700
| -15% | -$1.37M |
|
|
TE
2118
T1 Energy
TE
$1.33B
| $8.59M | ﹤0.01% |
918,215
+689,109
| +301% | +$5.18M |
|
2119
CALL
Alnylam Pharmaceuticals
ALNY
$32B
| $8.59M | ﹤0.01% |
+45,200
| New | +$8.96M |
|
2120
Kohl's
KSS
$2.03B
| $8.58M | ﹤0.01% |
372,369
-1,623,624
| -81% | -$35.1M |
|
|
LBRDK
2121
DELISTED
Liberty Broadband Class C
LBRDK
| $8.58M | ﹤0.01% |
107,081
-39,432
| -27% | -$3.05M |
|
2122
Aclaris Therapeutics
ACRS
$911M
| $8.58M | ﹤0.01% |
827,084
+766,221
| +1,259% | +$6.93M |
|
2123
Match Group
MTCH
$9.66B
| $8.57M | ﹤0.01% |
204,685
-757,700
| -79% | -$27.7M |
|
2124
BlackLine
BL
$1.82B
| $8.56M | ﹤0.01% |
159,121
+34,551
| +28% | +$1.92M |
|
2125
PUT
Moody's
MCO
$89.1B
| $8.55M | ﹤0.01% |
24,600
+23,700
| +2,633% | +$7.51M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.